2m 2m 2m 2m 2m 2m 2m
Biocryst Pharm (BCRX)
NASDAQ
$9.94+$0.03 (+0.29%)
Price as of Jul 14, 2026 6:00 AM EDT- $2.5BMarket Cap
- 10.60%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Biocryst Pharm (BCRX)
$9.94+$0.03 (+0.29%)
BCRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.91 | ||
Change | -$0.54 (-5.17%) | ||
Open | $10.13 | ||
High | $10.23 | ||
Low | $9.80 | ||
Previous Close | $10.45 | ||
Volume | 3,147,935 | ||
30-Day Average Volume | 6,775,596 | ||
1-Week Change | -2.56% | ||
1-Month Change | 13.91% | ||
1-Year Change | 10.60% | ||
3-Year Change | 34.83% | ||
5-Year Change | -37.56% | ||
Fundamentals | |||
Shares Outstanding | 254.2M | ||
Total Assets | $465.1M | ||
Market Cap | $2.5B | ||
Enterprise Value | $2.7B | ||
Period: QTR TTM FY | |||
Revenue | $151.4M | ||
Net Income | -$721.8M | ||
Free Cash Flow | -$62.2M | ||
EBIT | -$714.6M | ||
EBITDA | -$714.0M | ||
Net Working Capital | $178.2M | ||
EPS | -$2.98 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | 18 | ||
P/B | -5 | ||
P/E | -3 | ||
PEG | 0 | ||
Price/Free Cash Flow | -40 | ||
Price/Operating Cash Flow | -41 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue